2014
DOI: 10.5306/wjco.v5.i3.299
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of breast cancer therapeutics: Breast tumour kinase’s role in breast cancer and hope for breast tumour kinase targeted therapy

Abstract: Core tip: Breast tumour kinase/protein tyrosine kinase 6 is overexpressed in up to 86% of invasive breast cancers. It plays a key role in regulating a number of cell processes that are involved in the metastatic process. As a kinase involved in both epidermal growth factor and insulin like growth factors signaling, inhibiting its activity could prove to be an effective way to enhance the effects of current targeted treatments. In addition, disrupting the protein-protein interactions central for the kinase-inde… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 90 publications
0
6
0
Order By: Relevance
“…Moreover, betulin (3) further activates the crucial apoptotic markers, ie, BAK / BAX , HRK and caspases family proteins, while inhibiting BCL-2L1 44. Reports suggest that osteopontin shuts off these proteins and indirectly activates anti-apoptotic BCL-2L1 via COX-2 pathway to inhibit the intrinsic pathway of apoptosis 45…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, betulin (3) further activates the crucial apoptotic markers, ie, BAK / BAX , HRK and caspases family proteins, while inhibiting BCL-2L1 44. Reports suggest that osteopontin shuts off these proteins and indirectly activates anti-apoptotic BCL-2L1 via COX-2 pathway to inhibit the intrinsic pathway of apoptosis 45…”
Section: Discussionmentioning
confidence: 99%
“…Exosomes are also involved in the regulation of pathological angiogenesis, including tumor angiogenesis (29). Especially in response to enhanced exosome production due to intratumoral hypoxia, the uptake of cancer cell-derived exosomes by endothelial cells (ECs) stimulates angiogenesis (30).…”
Section: Exosomes In Tumor Angiogenesismentioning
confidence: 99%
“…Understanding the interplay between the microenvironment and tumor cells is critical in developing novel therapies. Although enhanced CAF activity by tumor secreted growth factors is well documented, it is still not clear what initiates CAF activation [16].…”
Section: Predictive Biomarkers and Therapeutic Targetsmentioning
confidence: 99%